Health Topics — Skin & Topical
How Topical Cannabinoids Work — and What to Realistically Expect
A plain account of how cannabinoids behave in skin tissue, what the research has established about delivery, and why topical and oral preparations work through different mechanisms.
A topical CBD or CBG preparation is not the same as an oral one applied to the outside of the body. It is a different route with different biology, different targets, and different expectations. Most of the confusion about what topical cannabinoids can do comes from not understanding that distinction clearly — and most of the disappointment comes from expecting a topical preparation to do what an oral one does, or vice versa.
This is a plain account of what the research actually shows about how cannabinoids behave when applied to skin.
The stratum corneum — the outermost layer of skin — is designed to keep things out. It is an effective barrier against water loss, environmental toxins, and pathogens. It is also a barrier against most molecules applied topically, including most cannabinoids. Getting past it is not impossible, but it is not automatic either. The question of whether and how much CBD or CBG reaches the viable skin layers beneath the stratum corneum is central to understanding what topical preparations can do.
Research has confirmed that cannabinoids do penetrate human skin. They cross the stratum corneum and reach the viable epidermis — the layer where most skin cells live and where the skin's cannabinoid receptors are expressed. Some research has found penetration into the dermis as well. What has not been established for standard oil-based preparations is meaningful transdermal delivery — significant concentrations reaching the bloodstream after topical application. Engineered patch systems with chemical permeation enhancers have demonstrated transdermal delivery in animal models. Standard massage oils and topical preparations have not shown this in the research that exists.
This is not a limitation — it is an accurate description of how topical preparations work. The target of a topical cannabinoid preparation is the skin itself: the keratinocytes, the sebaceous glands, the skin-resident immune cells, the sensory nerve endings in the dermis. These tissues express the receptors cannabinoids interact with. A topical preparation acts locally in those tissues. It is not a slower or weaker version of oral delivery — it is a different mechanism with its own appropriate applications.
What topical cannabinoids can and cannot reasonably be expected to do
Local skin effects — reducing inflammatory signaling in skin-resident immune cells, interacting with sensory receptors involved in itch and localized pain, influencing keratinocyte behavior — are the territory where topical cannabinoid research is most plausible and where the biology most directly supports the application. The endocannabinoid receptors in skin are real, their involvement in skin inflammation and sensation is documented, and topical delivery reaches the tissue where those receptors are expressed.
Systemic effects — stress regulation, sleep, mood, the kinds of effects that oral CBG preparations interact with — are not what a topical preparation is designed to produce. Someone who tries a topical CBD preparation expecting the kind of whole-body settling associated with an oral dose will likely be disappointed, not because the preparation isn't working, but because they are expecting it to work through a mechanism it doesn't use.
Joint pain sits in an interesting middle territory. The synovial tissue of joints expresses cannabinoid receptors. Animal research has found that transdermal CBD gel formulations — again, with permeation enhancers — reached joint tissue and reduced inflammation in arthritis models. For standard topical preparations, joint penetration is less established. The joint is surrounded by more tissue than the surface of the skin, and whether cannabinoids from a standard topical preparation reach meaningful concentrations there is not confirmed by existing research. The mechanistic case is plausible; the evidence for standard preparations is limited.
On carrier oils and formulation
The carrier oil in a topical preparation matters. Oils with smaller molecular weight and established skin penetration profiles — jojoba, which mimics the skin's own sebum, and sunflower, which is high in linoleic acid relevant to skin barrier function — support the delivery of cannabinoids into skin layers better than heavier oils that remain primarily on the surface. This is one reason formulation is not interchangeable between products, even those with similar cannabinoid concentrations.
What realistic expectations look like
A topical cannabinoid preparation applied to inflamed skin or a sore joint is acting locally in that tissue, through receptors that are genuinely present and genuinely responsive to cannabinoid signaling. Whether it does something useful depends on whether the concentration that reaches the relevant tissue is sufficient to produce an effect — which is the open question the research has not yet answered for standard preparations.
The honest expectation: local activity in skin tissue is supported by the biology. Whether that local activity is sufficient to produce noticeable clinical benefit — reduced redness, reduced itch, localized pain relief — is not established by controlled trials for any of our preparations or for cannabinoid topicals generally. Some people report clear benefit. The research that would confirm or characterize that benefit at a population level has not been done.
Topical and oral cannabinoid preparations are not the same thing applied differently — they are different mechanisms with different targets. Understanding that distinction is the most practically useful thing this article can offer. The skin research is developing. The delivery questions are real and open. We will update this article as the evidence fills in those gaps.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.